RU2435609C2 - КОМБИНИРОВАННЫЕ ВАКЦИНЫ С НИЗКОЙ ДОЗОЙ КОНЪЮГАТА Hib - Google Patents

КОМБИНИРОВАННЫЕ ВАКЦИНЫ С НИЗКОЙ ДОЗОЙ КОНЪЮГАТА Hib Download PDF

Info

Publication number
RU2435609C2
RU2435609C2 RU2006136212/15A RU2006136212A RU2435609C2 RU 2435609 C2 RU2435609 C2 RU 2435609C2 RU 2006136212/15 A RU2006136212/15 A RU 2006136212/15A RU 2006136212 A RU2006136212 A RU 2006136212A RU 2435609 C2 RU2435609 C2 RU 2435609C2
Authority
RU
Russia
Prior art keywords
hib
vaccine
conjugate
antigen
tetanus
Prior art date
Application number
RU2006136212/15A
Other languages
English (en)
Russian (ru)
Other versions
RU2006136212A (ru
Inventor
Марио КОНТОРНИ (IT)
Марио Конторни
Original Assignee
Чирон С.Р.Л.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32117706&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=RU2435609(C2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Чирон С.Р.Л. filed Critical Чирон С.Р.Л.
Publication of RU2006136212A publication Critical patent/RU2006136212A/ru
Application granted granted Critical
Publication of RU2435609C2 publication Critical patent/RU2435609C2/ru

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/08—Clostridium, e.g. Clostridium tetani
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/05—Actinobacteria, e.g. Actinomyces, Streptomyces, Nocardia, Bifidobacterium, Gardnerella, Corynebacterium; Propionibacterium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/099—Bordetella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Steroid Compounds (AREA)
RU2006136212/15A 2004-03-15 2005-03-14 КОМБИНИРОВАННЫЕ ВАКЦИНЫ С НИЗКОЙ ДОЗОЙ КОНЪЮГАТА Hib RU2435609C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0405787.3A GB0405787D0 (en) 2004-03-15 2004-03-15 Low dose vaccines
GB0405787.3 2004-03-15

Publications (2)

Publication Number Publication Date
RU2006136212A RU2006136212A (ru) 2008-04-27
RU2435609C2 true RU2435609C2 (ru) 2011-12-10

Family

ID=32117706

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2006136212/15A RU2435609C2 (ru) 2004-03-15 2005-03-14 КОМБИНИРОВАННЫЕ ВАКЦИНЫ С НИЗКОЙ ДОЗОЙ КОНЪЮГАТА Hib

Country Status (13)

Country Link
US (2) US20090208526A1 (enExample)
EP (1) EP1725258B1 (enExample)
JP (2) JP4954056B2 (enExample)
CN (2) CN102028944B (enExample)
AT (1) ATE480257T1 (enExample)
BR (1) BRPI0508813B8 (enExample)
CA (1) CA2559996C (enExample)
DE (1) DE602005023422D1 (enExample)
DK (1) DK1725258T3 (enExample)
GB (1) GB0405787D0 (enExample)
RU (1) RU2435609C2 (enExample)
SG (1) SG151253A1 (enExample)
WO (1) WO2005089794A2 (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2626532C2 (ru) * 2015-01-16 2017-07-28 Федеральное государственное унитарное предприятие "Научно-производственное объединение по медицинским иммунобиологическим препаратам "Микроген" Министерства здравоохранения Российской Федерации Комбинированная вакцина для профилактики коклюша, дифтерии, столбняка, гепатита в и инфекции, вызываемой haemophilus influenzae тип в
EA039237B1 (ru) * 2012-10-29 2021-12-21 Дзе Борд Оф Трастиз Оф Дзе Юниверсити Оф Арканзас Применение маннозилированного хитозана в качестве адъюванта в составе вакцин для пероральной или мукозной доставки

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100898845B1 (ko) * 2000-06-29 2009-05-21 글락소스미스클라인 바이오로지칼즈 에스.에이. 다가 백신 조성물
GB0505518D0 (en) * 2005-03-17 2005-04-27 Chiron Srl Combination vaccines with whole cell pertussis antigen
KR101359953B1 (ko) 2005-06-27 2014-02-21 글락소스미스클라인 바이오로지칼즈 에스.에이. 면역원성 조성물
CN103585624A (zh) 2006-09-07 2014-02-19 葛兰素史密丝克莱恩生物有限公司 疫苗
GB0700135D0 (en) * 2007-01-04 2007-02-14 Glaxosmithkline Biolog Sa Vaccine
WO2008149238A2 (en) * 2007-06-04 2008-12-11 Novartis Ag Formulation of meningitis vaccines
CU23652A1 (es) * 2007-06-29 2011-05-27 Centro Inmunologia Molecular Composición vacunal homogénea para el tratamiento del cáncer y su método de obtención
EP2457590B1 (en) * 2008-05-01 2014-12-24 Arecor Limited Protein formulation
PE20100365A1 (es) 2008-10-24 2010-05-21 Panacea Biotec Ltd Novedosas vacunas de combinacion con tos ferina de celulas enteras y metodo para su elaboracion
PE20100366A1 (es) 2008-10-24 2010-05-21 Panacea Biotec Ltd Novedosas composiciones de vacuna con tos ferina acelular asi como el metodo para su elaboracion
GB0822633D0 (en) * 2008-12-11 2009-01-21 Novartis Ag Formulation
NZ598654A (en) 2009-09-02 2014-05-30 Novartis Ag Immunogenic compositions including tlr activity modulators
BR112012014689B1 (pt) * 2009-12-16 2019-11-12 Serum Institute Of India Private Limited composição imunogênica
CN105999275A (zh) 2010-09-01 2016-10-12 诺华有限公司 免疫增强剂吸附不溶性金属离子
WO2012117377A1 (en) * 2011-03-02 2012-09-07 Novartis Ag Combination vaccines with lower doses of antigen and/or adjuvant
AU2012245198B2 (en) * 2011-04-21 2017-07-13 Trustees Of Tufts College Compositions and methods for stabilization of active agents
RU2014140521A (ru) 2012-03-08 2016-04-27 Новартис Аг Адъювантные составы бустерных вакцин
US11027005B2 (en) * 2016-10-20 2021-06-08 Km Biologics Co., Ltd. Method for producing Hib conjugate vaccine using PRP with lowered molecular weight
JP7404226B2 (ja) 2017-07-18 2023-12-25 セラム インスティテュート オブ インディア プライベート リミティド 向上した安定性、高度の免疫原性、及び減少した反応源性を有する免疫原性組成物、並びにその調製プロセス
CN110251667A (zh) * 2018-05-11 2019-09-20 武汉博沃生物科技有限公司 一种免疫组合制剂及其制备方法和应用
JOP20190242A1 (ar) 2018-10-12 2020-04-12 Serum Institute Of India Pvt Ltd تركيبة لقاح توليفي تشمل فيروس شلل الأطفال ذو جرعة مخفّضة خاملة التنشيط وطريقة لتحضيرها
WO2021176409A1 (en) 2020-03-05 2021-09-10 Sanofi Healthcare India Private Limited Preservative combination for vaccine composition
CN118903397A (zh) * 2024-10-12 2024-11-08 成都迈科康生物科技有限公司 GloboH六糖、linker化合物、蛋白偶联物及免疫原性组合物在治疗或抑制上皮性肿瘤中的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2734484B1 (fr) * 1995-05-24 1997-06-27 Pasteur Merieux Serums Vacc Composition vaccinale liquide et procede de fabrication
US20020054884A1 (en) * 1995-06-23 2002-05-09 Smithkline Beecham Biologicals, Sa Vaccine composition comprising a polysaccharide conjugate antigen adsorbed onto aluminium phosphate
EP0833662B2 (en) * 1995-06-23 2011-01-26 SmithKline Beecham Biologicals S.A. A vaccine composition comprsing a Haemophilus influenzae B polysaccharide conjugate antigen adsorbed onto aluminium phosphate
KR100898845B1 (ko) * 2000-06-29 2009-05-21 글락소스미스클라인 바이오로지칼즈 에스.에이. 다가 백신 조성물

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
AMIR J. et al. Immunogenicity and safety of a liquid combination. Of DT-PRP-T vs lyophilized PRP-T recontituted with DTP, VACCINE, BUTTERWORTH SCIENTIFIC, GUILDFORD, GB, 1997, v.15, №2, pp.149-154. NICOL M., et al. Haemophilus influenzae type В conjugate vaccine diluted tenfold in diphtheria-tetanus-whole cell pertussis vaccine: A randomized trial, Pediatric Infectious Disease Journal, 2002, v. 21, №2, pp.138-141. *
NICOL M., et al. Haemophilus influenzae type В conjugate vaccine diluted tenfold in diphtheria-tetanus-whole cell pertussis vaccine: A randomized trial, Pediatric Infectious Disease Journal, 2002, v. 21, №2, pp.138-141. *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA039237B1 (ru) * 2012-10-29 2021-12-21 Дзе Борд Оф Трастиз Оф Дзе Юниверсити Оф Арканзас Применение маннозилированного хитозана в качестве адъюванта в составе вакцин для пероральной или мукозной доставки
RU2626532C2 (ru) * 2015-01-16 2017-07-28 Федеральное государственное унитарное предприятие "Научно-производственное объединение по медицинским иммунобиологическим препаратам "Микроген" Министерства здравоохранения Российской Федерации Комбинированная вакцина для профилактики коклюша, дифтерии, столбняка, гепатита в и инфекции, вызываемой haemophilus influenzae тип в

Also Published As

Publication number Publication date
CN1968711B (zh) 2011-01-05
DK1725258T3 (da) 2010-11-01
EP1725258B1 (en) 2010-09-08
CA2559996C (en) 2014-08-05
CA2559996A1 (en) 2005-09-29
BRPI0508813B1 (pt) 2019-05-21
ATE480257T1 (de) 2010-09-15
US20120107346A1 (en) 2012-05-03
JP4954056B2 (ja) 2012-06-13
CN102028944A (zh) 2011-04-27
CN1968711A (zh) 2007-05-23
JP2007529503A (ja) 2007-10-25
BRPI0508813B8 (pt) 2021-05-25
SG151253A1 (en) 2009-04-30
US20090208526A1 (en) 2009-08-20
CN102028944B (zh) 2013-12-04
US9259460B2 (en) 2016-02-16
RU2006136212A (ru) 2008-04-27
DE602005023422D1 (de) 2010-10-21
JP2008150397A (ja) 2008-07-03
WO2005089794A2 (en) 2005-09-29
EP1725258A2 (en) 2006-11-29
BRPI0508813A (pt) 2007-08-07
WO2005089794A3 (en) 2006-03-09
GB0405787D0 (en) 2004-04-21

Similar Documents

Publication Publication Date Title
RU2435609C2 (ru) КОМБИНИРОВАННЫЕ ВАКЦИНЫ С НИЗКОЙ ДОЗОЙ КОНЪЮГАТА Hib
JP6035293B2 (ja) 共通キャリアタンパク質を有する混合型髄膜炎菌結合体
EP2066344B1 (en) Inactivated Poliovirus combination vaccine
RU2429011C2 (ru) Вакцинация менингококковыми конъюгатами
ES2690526T3 (es) Composiciones inmunogénicas
RU2379052C2 (ru) Вакцинация менингококковыми конъюгатами
HK1156257A (en) Combination vaccines with low dose of hib conjugate

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20180315